EP.17A.04 Real-World Rates of Infusion-Related Reactions in Patients with EGFR-Mutant NSCLC Receiving Amivantamab

Autor: Gupta, D.M., Chang, C., Wendt, L., Mohindra, N., Chae, Y., Tobben, D., Gharzai, L.A., Patel, J.D.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S713-S713
Databáze: ScienceDirect